NCT06570824
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +18 more
- Locations
-
- DRCMR Hvidovre, Denmark
Clinical trial condition
Dyskinesia, Drug-Induced
Explore clinical trials studying Dyskinesia, Drug-Induced. Study availability and eligibility vary by location and protocol.
9 public trials
1 recruiting study
Dyskinesia, Drug-Induced trial results
Completed
Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors
NCT04064294
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
- Locations
-
- VA Portland Health Care System, Portland, OR Portland, Oregon, United States
- Oregon Health & Science University Portland, Oregon, United States
- VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle, Washington, United States
Completed
Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia
NCT05297201
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- Mazowiecki Szpital Bródnowski Warsaw, Masovian Voivodeship, Poland
- Instytut Zdrowia dr Boczarska-Jedynak Sp. Z o.o., Sp. K., Oświęcim, Małopolska, Poland
- Cherkasy Regional Hospital of the Cherkasy Regional Council Cherkasy, Ukraine
- Ukrainian State Research Institute of Medical and Social Problems of Disability of the Ministry of Health of Ukraine, Department of Neurology and Borderline Conditions; Dnipro, Ukraine
NCT05148884
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- Sahlgrenska Hospital Gothenburg, Sweden
- Skåne University Hospital Lund, Sweden
- ASC Torsplan Stockholm, Sweden
- Karolinska University Hospital, Solna Stockholm, Sweden
NCT01173731
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- Novartis Investigative Site Sunnyvale, California, United States
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Indianapolis, Indiana, United States
- Novartis Investigative Site Heidelberg, Victoria, Australia
Completed
Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease
NCT03354455
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
- Locations
-
- Danish Research Centre for Magnetic Resonance Hvidovre, Capital Region, Denmark
Completed
Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)
NCT02657681
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- CINAC, Hospital Universitario Puerta del Sur Móstoles, Madrid, Spain
NCT00175955
- Conditions
- Central Nervous System Diseases, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +10 more
- Locations
-
- Antwerp, Belgium
- Bourgois, Belgium
- Gonce, Belgium
- Hulselmans, Belgium
NCT00255879
- Conditions
- Central Nervous System Diseases, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +13 more
- Locations
-
- University of California, San Diego Division of Geriatric Psychiatry San Diego, California, United States